Home/Enthorin Therapeutics/J. Guy Breitenbucher, Ph.D.

JG

J. Guy Breitenbucher, Ph.D.

Co-Founder

Enthorin Therapeutics

Therapeutic Areas

Neurodevelopmental Disorders Neurodegenerative Diseases

Enthorin Therapeutics Pipeline

Drug	Indication	Phase
ENT-3379	Fragile X Syndrome	Phase 1
Platform Asset	Autism Spectrum Disorders	Pre-clinical

Leadership Team at Enthorin Therapeutics

Marco Peters, Ph.D.

Michael A. Yassa, Ph.D.

View full Enthorin Therapeutics profile